open access

Vol 66, No 2 (2016)
Brief communication
Published online: 2016-06-01
Get Citation

Initial experiences of the use of electrochemotherapy in the treatment of skin metastases

Mateusz Wichtowski, Dawid Murawa, Maria Litwiniuk, Joanna Kufel-Grabowska, Artur Bocian, Wojciech Witkiewicz
·
Nowotwory. Journal of Oncology 2016;66(2):127-135.

open access

Vol 66, No 2 (2016)
Preliminary report
Published online: 2016-06-01

Abstract

Introduction. Electrochemotherapy (ECT) is an ablation method based on a reversible electroporation combination with concurrent chemotherapy (intravenous administration or directly into the tumour). This method has been used in the treatment of primary skin tumours (carcinomas, melanomas) and secondary malignancies (e.g. breast cancer metastases) which were unfit or unresponsive to a different type of treatment. It is a palliative method aimed at improving the quality of life.

Material and methods. Between February and May 2015 seven patients with metastatic breast cancer to the skin and subcutaneous tissue, and one patient with recurrent melanoma in the skin after groin lymphadenectomy, underwent the ECT procedure.

Results. For the patients treated by ECT, there were a total of 10 procedures for 50 target lesions. Seven patients underwent one course, one patient received three courses because of extension of the lesions. In 87.5% of the lesions good local effect as a complete or partial remission was observed. Patients remain under close observation and control.

Conclusions. The results show that ECT is an effective and safe therapeutic option for the treatment of unresectable skin malignances, especially in the case of prior use of other available methods of cancer treatment.  

Abstract

Introduction. Electrochemotherapy (ECT) is an ablation method based on a reversible electroporation combination with concurrent chemotherapy (intravenous administration or directly into the tumour). This method has been used in the treatment of primary skin tumours (carcinomas, melanomas) and secondary malignancies (e.g. breast cancer metastases) which were unfit or unresponsive to a different type of treatment. It is a palliative method aimed at improving the quality of life.

Material and methods. Between February and May 2015 seven patients with metastatic breast cancer to the skin and subcutaneous tissue, and one patient with recurrent melanoma in the skin after groin lymphadenectomy, underwent the ECT procedure.

Results. For the patients treated by ECT, there were a total of 10 procedures for 50 target lesions. Seven patients underwent one course, one patient received three courses because of extension of the lesions. In 87.5% of the lesions good local effect as a complete or partial remission was observed. Patients remain under close observation and control.

Conclusions. The results show that ECT is an effective and safe therapeutic option for the treatment of unresectable skin malignances, especially in the case of prior use of other available methods of cancer treatment.  

Get Citation
About this article
Title

Initial experiences of the use of electrochemotherapy in the treatment of skin metastases

Journal

Nowotwory. Journal of Oncology

Issue

Vol 66, No 2 (2016)

Article type

Brief communication

Pages

127-135

Published online

2016-06-01

Page views

818

Article views/downloads

2401

DOI

10.5603/NJO.2016.0022

Bibliographic record

Nowotwory. Journal of Oncology 2016;66(2):127-135.

Authors

Mateusz Wichtowski
Dawid Murawa
Maria Litwiniuk
Joanna Kufel-Grabowska
Artur Bocian
Wojciech Witkiewicz

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl